A Study to Investigate Fadraciclib (CYC065), in Subjects With Advanced Solid Tumors and Lymphoma

Clinical trial NCT04983810 · UNKNOWN

Trial details

NCT number: NCT04983810
Sponsor: Cyclacel Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult Lymphoma

Start date: 2021-07-12
Primary completion: 2025-04-30
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.